Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
The lack of validated immunological correlates of protection makes tuberculosis vaccine development difficult and expensive. Using intradermal bacille Calmette-Guréin (BCG) as a surrogate for aerosol Mycobacterium tuberculosis (M.tb) in a controlled human infection model could facilitate vaccine dev...
Main Authors: | Harris, S, White, A, Stockdale, L, Tanner, R, Sibley, L, Sarfas, C, Meyer, J, Peter, J, O'Shea, M, Manjaly Thomas, Z, Hamidi, A, Satti, I, Dennis, M, McShane, H, Sharpe, S |
---|---|
פורמט: | Journal article |
יצא לאור: |
Elsevier
2017
|
פריטים דומים
-
A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
מאת: Tanner, R, et al.
יצא לאור: (2021) -
Optimisation of a human BCG challenge model
מאת: Wilkie, M, et al.
יצא לאור: (2015) -
MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates
מאת: Peralta-Álvarez, MP, et al.
יצא לאור: (2024) -
Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
מאת: Harris, S, et al.
יצא לאור: (2013) -
Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
מאת: Harris, SA, et al.
יצא לאור: (2014)